{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:16:44Z","timestamp":1790641004734,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"WHO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["207569\/Z\/17\/Z"],"award-info":[{"award-number":["207569\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2018.11.010","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T10:12:06Z","timestamp":1544177526000},"page":"A166-A173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"S1","title":["Modelling to inform prophylaxis regimens to prevent human rabies"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-6884","authenticated-orcid":false,"given":"Katie","family":"Hampson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6777-5298","authenticated-orcid":false,"given":"Bernadette","family":"Abela-Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-1503","authenticated-orcid":false,"given":"Omesh","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"L\u00e9chenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolande","family":"Mindekem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-7958","authenticated-orcid":false,"given":"Arnaud","family":"Tarantola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Zinsstag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4000-2708","authenticated-orcid":false,"given":"Caroline","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.010_b0005","article-title":"the beginning of the end of rabies?","volume":"2016","author":"Abela-Ridder","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2018.11.010_b0010","unstructured":"WHO expert consultation on rabies. Third report (WHO technical report series, no. 1012). Geneva: World Health Organization; 2018."},{"issue":"3","key":"10.1016\/j.vaccine.2018.11.010_b0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2471\/BLT.16.173039","article-title":"Pre-exposure rabies prophylaxis: a systematic review","volume":"95","author":"Kessels","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.11.010_b0020","first-page":"201","article-title":"Rabies vaccines and immunoglobulins: WHO position","volume":"16","author":"WHO","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"10.1016\/j.vaccine.2018.11.010_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000982","article-title":"Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries","volume":"5","author":"Hampson","year":"2011","journal-title":"Plos Neglect Trop Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2018.11.010_b0035","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2018.11.010_b0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"Both","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.11.010_b0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/21645515.2016.1255834","article-title":"Injecting rabies immunoglobulin (RIG) into wounds only: a significant saving of lives and costly RIG","volume":"13","author":"Bharti","year":"2017","journal-title":"Hum Vacc Immunotherapeut"},{"issue":"3","key":"10.1016\/j.vaccine.2018.11.010_b0050","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/21645515.2015.1085142","article-title":"Local infiltration of rabies immunoglobulins without systemic intramuscular administration: an alternative cost effective approach for passive immunization against rabies","volume":"12","author":"Bharti","year":"2016","journal-title":"Hum Vacc Immunotherapeut"},{"issue":"1","key":"10.1016\/j.vaccine.2018.11.010_b0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3201\/eid1301.060810","article-title":"Rabies encephalitis in malaria-endemic area, Malawi Africa","volume":"13","author":"Mallewa","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2018.11.010_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000339","article-title":"Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies","volume":"2","author":"Hampson","year":"2008","journal-title":"Plos Neglect Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.11.010_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000511","article-title":"Rabies situation in Cambodia","volume":"3","author":"Ly","year":"2009","journal-title":"Plos Neglect Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.11.010_b0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jtm.12228","article-title":"Rabes vaccine and rabies immunoglobuin in Cambodia: use and obstacles to use","volume":"22","author":"Tarantola","year":"2015","journal-title":"Int Soc Travel Med"},{"issue":"38","key":"10.1016\/j.vaccine.2018.11.010_b0075","article-title":"Description and comparative cost efficiency of post-exposure prophylaxis and canine mass vaccination against rabies in N\u2019Djamena, Chad","volume":"4","author":"Mindekem","year":"2017","journal-title":"Front Veterin Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2018.11.010_b0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/aje\/kwx234","article-title":"Rabies postexposure prophylaxis noncompletion after dog bites: estimating the unseen to meet the needs of the underserved","volume":"187","author":"Tarantola","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2018.11.010_b0085","doi-asserted-by":"crossref","first-page":"e2510","DOI":"10.1371\/journal.pntd.0002510","article-title":"The burden of rabies in Tanzania and its impact on local communities","volume":"7","author":"Sambo","year":"2013","journal-title":"Plos Neglect Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.11.010_b0090","doi-asserted-by":"crossref","first-page":"e0003786","DOI":"10.1371\/journal.pntd.0003786","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"Plos Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2018.11.010_b0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.actatropica.2016.04.015","article-title":"A prospective study on the incidence of dog bites and management in a rural Cambodian, rabies-endemic setting","volume":"160","author":"Ponsich","year":"2016","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2018.11.010_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/tropicalmed2030043","article-title":"The importance of a participatory and integrated one health approach for rabies control: the case of N\u2019Djam\u00e9na, Chad","volume":"2","author":"L\u00e9chenne","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.010_b0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2458-14-193","article-title":"Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa","volume":"14","author":"Grout","year":"2014","journal-title":"BMC Public Health"},{"issue":"51","key":"10.1016\/j.vaccine.2018.11.010_b0110","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1016\/j.vaccine.2009.09.027","article-title":"Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania","volume":"27","author":"Shim","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.010_b0115","series-title":"WHO expert committee on rabies seventh report","author":"WHO","year":"1984"},{"key":"10.1016\/j.vaccine.2018.11.010_b0120","unstructured":"WHO. WHO expert committee on rabies, 8th report. Geneva, Switzerland, 1992 Contract No.: WHO technical report series, no. 824."},{"issue":"RR2, Suppl. S","key":"10.1016\/j.vaccine.2018.11.010_b0125","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"Morbid Mortal Week Rep"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.11.010_b0130","doi-asserted-by":"crossref","first-page":"S758","DOI":"10.1093\/clinids\/10.Supplement_4.S758","article-title":"Current issues in human rabies immunization","volume":"10","author":"Vodopija","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.11.010_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CVI.00531-14","article-title":"Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination","volume":"22","author":"Ren","year":"2015","journal-title":"Clin Vacc Immunol: CVI"},{"issue":"16","key":"10.1016\/j.vaccine.2018.11.010_b0140","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.vaccine.2006.01.051","article-title":"Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection","volume":"24","author":"Khawplod","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.010_b0145","article-title":"Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003\u20132014","author":"Tarantola","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2018.11.010_b0150","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/21645515.2015.1048938","article-title":"Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases","volume":"11","author":"Narayana","year":"2015","journal-title":"Hum Vacc Immunotherapeut"},{"issue":"1","key":"10.1016\/j.vaccine.2018.11.010_b0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/649211","article-title":"Postexposure rabies prophylaxis completed in 1 week: preliminary study","volume":"50","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2018.11.010_b0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/hv.20471","article-title":"Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India","volume":"8","author":"Sudarshan","year":"2012","journal-title":"Hum Vacc Immunotherapeut"},{"issue":"4","key":"10.1016\/j.vaccine.2018.11.010_b0165","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1371\/journal.pntd.0000224","article-title":"A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods","volume":"2","author":"Warrell","year":"2008","journal-title":"Plos Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2018.11.010_b0170","series-title":"Handbook of clinical neurology","article-title":"Rabies","author":"Hemachudha","year":"1989"},{"issue":"48","key":"10.1016\/j.vaccine.2018.11.010_b0180","first-page":"729","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2017 \u2013 conclusions and recommendations","volume":"92","author":"WHO","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2018.11.010_b0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QCO.0000000000000420","article-title":"Rabies: changing prophylaxis and new insights in pathophysiology","volume":"31","author":"Ugolini","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.11.010_b0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2018.11.010_b0195","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/S0264-410X(02)00299-2","article-title":"Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine","volume":"20","author":"Kamoltham","year":"2002","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2018.11.010_b0200","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1016\/j.vaccine.2018.11.011","article-title":"Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar","volume":"37","author":"Rajeev","year":"2019","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2018.11.010_b0205","doi-asserted-by":"crossref","first-page":"A45","DOI":"10.1016\/j.vaccine.2018.08.086","article-title":"The need to improve access to rabies post-exposure vaccines: lessons from Tanzania","volume":"37","author":"Changalucha","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.010_b0210","article-title":"Surveillance to establish elimination of transmission and freedom from dog-mediated rabies","author":"Hampson","year":"2016","journal-title":"BioRxiv"},{"key":"10.1016\/j.vaccine.2018.11.010_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(17)30321-2","article-title":"Effect of counselling on health-care-seeking behaviours and rabies vaccination adherence after dog bites in Haiti, 2014\u201315: a retrospective follow-up survey","author":"Etheart","year":"2017","journal-title":"Lancet Global Health"},{"issue":"9","key":"10.1016\/j.vaccine.2018.11.010_b0220","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children","volume":"24","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T02:28:18Z","timestamp":1569551298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"alternative-id":["S0264410X18315196"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling to inform prophylaxis regimens to prevent human rabies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}